Results for “neurosurgery”
Deep Brain Stimulation
** Deep brain stimulation (DBS) is a surgically implanted neurostimulation therapy that delivers precise electrical pulses to targeted brain regions to modulate abnormal neural circuits in a variety of chronic neurological disorders. **CONTENT:** ## Overview Deep brain stimulation (DBS) is a **neurostimulation** technique that uses an implantable pulse generator (IPG) placed under the skin of the chest, connected via insulated leads to specific deep brain nuclei. The device emits controlled electrical impulses that **bidirectionally** influence neuronal activity—both **ante‑grade** (forward) and **retrograde** (backward) signaling—thereby disrupting pathological circuit patterns while promoting more normal firing. Unlike lesioning procedures that permanently destroy tissue, DBS is adjustable, reversible, and can be fine‑tuned over time to match a patient’s evolving symptoms. Clinically, DBS is most widely recognized for its ability to alleviate **Parkinsonian tremor**, rigidity, and bradykinesia, but its therapeutic reach now includes **essential tremor**, **dystonia**, **obsessive‑compulsive disorder (OCD)**, **Tourette syndrome**, **epilepsy**, and emerging applications in **depression**, **Alzheimer’s disease**, and **chronic pain**. Candidates typically have medication‑refractory disease, and the decision to proceed involves a multidisciplinary team of neurologists, neurosurgeons, neuropsychologists, and rehabilitation specialists. **Important safety note:** If you or a loved one are considering DBS, consult a qualified neurologist or neurosurgeon for a comprehensive evaluation; DBS carries surgical risks and requires lifelong device management. ## History/Background The conceptual roots of DBS trace back to the 1960s, when researchers first observed that high‑frequency electrical stimulation could suppress abnormal neuronal firing in animal models. In 1987, **Alim-Louis Benabid** and colleagues demonstrated that chronic high‑frequency stimulation of the **ventral intermediate nucleus (VIM)** of the thalamus markedly reduced tremor in Parkinson’s patients, marking the first successful human application. The early 1990s saw the FDA grant **Humanitarian Device Exemption** for DBS in essential tremor, followed by a **1997 approval** for Parkinson’s disease. Throughout the 2000s, advances in imaging (MRI‑guided targeting), electrode design (directional leads), and IPG technology (programmable, rechargeable batteries) expanded the therapeutic landscape. In 2011, the FDA approved DBS for **essential tremor**, and in 2018 for **refractory OCD**. Ongoing clinical trials continue to explore DBS for **treatment‑resistant depression**, **Alzheimer’s disease**, and **obesity**, reflecting a shift from a purely motor‑disorder focus to broader neuropsychiatric applications. ## Key Information - **Device components:** IPG (battery‑powered pulse generator), lead(s) with multiple contacts, and a programmer for external adjustments. Modern IPGs may be **rechargeable** and capable of **closed‑loop** sensing, adjusting stimulation in real time based on neural feedback. - **Target nuclei:** Common targets include the **subthalamic nucleus (STN)** and **globus pallidus internus (GPi)** for Parkinson’s disease; the **VIM** for essential tremor; the **anterior limb of the internal capsule** for OCD; and the **centromedian thalamic nucleus** for certain epilepsy syndromes. - **Surgical procedure:** Performed under stereotactic guidance, the surgery involves drilling a burr hole, inserting the lead, and tunneling the extension to the chest where the IPG is implanted. Intra‑operative microelectrode recordings help refine placement. - **Efficacy:** Meta‑analyses report **30‑60% improvement** in motor scores for Parkinson’s disease and **50‑70% reduction** in tremor amplitude for essential tremor. Psychiatric indications show variable response, with roughly **40‑50%** of OCD patients achieving clinically meaningful improvement. - **Risks & complications:** Include infection, hemorrhage, lead migration, hardware failure, and stimulation‑related side effects such as dysarthria, paresthesia, or mood changes. Regular follow‑up is essential to balance therapeutic benefit against adverse effects. - **Regulatory status:** FDA‑approved for Parkinson’s disease, essential tremor, dystonia, and OCD; many other uses remain **off‑label** or under investigational study. ## Significance DBS represents a paradigm shift in neuromodulation, offering a **reversible, adjustable** alternative to ablative brain surgery. Its capacity to modulate dysfunctional circuits without destroying tissue has transformed the management of movement disorders, granting many patients restored independence and quality of life. The technology also serves as a **research platform**, allowing scientists to probe the causal role of specific brain networks in cognition, emotion, and behavior. Beyond individual patient benefit, DBS has spurred interdisciplinary collaboration among neurosurgery, biomedical engineering, neurophysiology, and psychiatry, accelerating innovations such as **directional leads**, **adaptive closed‑loop systems**, and **machine‑learning‑driven programming**. As the field matures, DBS may become a cornerstone of personalized medicine for a spectrum of neuropsychiatric conditions, illustrating how precise electrical modulation can complement pharmacologic and behavioral therapies. **INFOBOX:** - Name: Deep Brain Stimulation (DBS) - Type: Implantable neurostimulation therapy - Date: First human use 1987 (Benabid) - Location: Operates within deep brain nuclei; IPG implanted sub‑clavicularly - Known For: Reversible electrical modulation of pathological brain circuits for movement and psychiatric disorders **TAGS:** deep brain stimulation, neurostimulation, Parkinson's disease, essential tremor, neurosurgery, brain implants, neuromodulation, psychiatric disorders
Health & MedicineBrain Tumors
Brain tumors are abnormal growths of cells within the brain that can be either malignant (cancerous) or benign (non-cancerous), leading to a range of symptoms and potential complications. ## Overview Brain tumors are a complex and multifaceted medical condition that affects millions of people worldwide. A brain tumor occurs when a group of cells within the brain grow out of control, creating a mass that can interfere with the normal functioning of the brain. There are two main types of tumors: malignant (cancerous) tumors and benign (non-cancerous) tumors. Malignant tumors are more aggressive and can spread to other parts of the brain or body, while benign tumors are typically slower-growing and less likely to spread. Brain tumors can be further classified as primary tumors, which start within the brain, and secondary tumors, which most commonly have spread from tumors located outside the brain, known as brain metastasis tumors. Primary brain tumors can arise from various types of brain cells, including neurons, glial cells, and blood vessels. Secondary brain tumors, on the other hand, are typically metastases from cancers that have spread from other parts of the body, such as the lungs, breast, or skin. Symptoms of brain tumors can vary depending on the size of the tumor and the part of the brain that is involved. Common symptoms include headaches, seizures, problems with vision, vomiting, and mental changes. Other symptoms may include difficulty walking, speaking, with sensations, or unconsciousness. In some cases, brain tumors may not produce any noticeable symptoms until they have grown significantly. ## History/Background The concept of brain tumors dates back thousands of years, with ancient civilizations such as the Egyptians and Greeks describing cases of brain tumors. However, it wasn't until the late 19th century that the first modern descriptions of brain tumors were made by physicians such as William Gowers and Harvey Cushing. Cushing, in particular, made significant contributions to the field of neurosurgery and was one of the first physicians to develop techniques for removing brain tumors. In the early 20th century, the development of imaging technologies such as X-rays and computed tomography (CT) scans revolutionized the diagnosis and treatment of brain tumors. Today, advanced imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) scans are used to diagnose and monitor brain tumors. ## Key Information * **Types of Brain Tumors**: There are over 120 different types of brain tumors, including gliomas, meningiomas, and acoustic neuromas. * **Causes and Risk Factors**: The exact causes of brain tumors are not fully understood, but risk factors include genetic mutations, exposure to radiation, and certain environmental toxins. * **Symptoms**: Common symptoms of brain tumors include headaches, seizures, problems with vision, vomiting, and mental changes. * **Diagnosis**: Brain tumors are typically diagnosed using imaging technologies such as MRI and CT scans. * **Treatment**: Treatment options for brain tumors include surgery, radiation therapy, and chemotherapy. * **Prognosis**: The prognosis for brain tumors varies depending on the type and location of the tumor, as well as the patient's overall health. ## Significance Brain tumors are a significant public health concern, with over 80,000 new cases diagnosed in the United States each year. Brain tumors can have a profound impact on patients and their families, causing significant emotional, physical, and financial burdens. However, advances in medical technology and treatment options have improved the prognosis for many patients with brain tumors. INFOBOX: - Name: Brain Tumors - Type: Medical Condition - Date: Ancient civilizations (descriptions of brain tumors date back thousands of years) - Location: Brain - Known For: Complex and multifaceted medical condition that affects millions of people worldwide TAGS: brain tumors, cancer, neurology, neurosurgery, medical imaging, radiation therapy, chemotherapy, prognosis, public health.